Panasonic

Article

The new Panasonic MDF-U76V ultra-low freezer combines improved cooling performance with outstanding energy efficiency.

Panasonic’s new MDF-U76V is the most energy-efficient 700 litre -86ºC freezer available

The new Panasonic MDF-U76V ultra-low freezer combines improved cooling performance with outstanding energy efficiency. The advantages include greater security for precious research or clinical samples, as well as significantly lower running costs and added environmental benefits. A leading independent test institute in the Netherlands has measured the power consumption of the MDF-U76V at 13.77kWh/24hr. Based on current published data, this makes the MDF-U76V the most energy-efficient 700 litre -86ºC freezer on the market.

This latest -86ºC VIP upright freezer has been specifically designed by Panasonic to meet the growing demand for energy savings, without in any way compromising freezer performance. In fact, cooling efficiency, insulation characteristics and door-open recovery times have all been enhanced through exclusive Panasonic innovations: a capillary tube heat exchanger, next-generation VIP PLUS insulation, and the Cool Safe compressor. As a result, greater temperature uniformity throughout the freezer and faster temperature pull-down contribute to industry-leading sample security.

Panasonic’s advanced new capillary tube heat exchanger significantly increases the overall efficiency of the freezer. By optimising the available heat exchange areas, system reliability is also increased and energy consumption is cut. In addition to helping minimise energy use, the high performance patented vacuum panels together with high-density foam insulation enable Panasonic VIP ULT freezers to provide up to 30 per cent more storage capacity than a conventionally insulated freezer, saving valuable lab space.

Recent Videos
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Related Content